Neurodegenerative diseases like Alzheimer’s and Parkinson’s are partly attributable to brain inflammation. Researchers now demonstrate that a well-known family of enzymes can prevent the inflammation and thus constitute a potential target for drugs.
Neurodegenerative diseases like Alzheimer’s and Parkinson’s are partly attributable to brain inflammation. Researchers now demonstrate that a well-known family of enzymes can prevent the inflammation and thus constitute a potential target for drugs.